List of Upsher-Smith Laboratories patents

List of Upsher-Smith Laboratories patents

List of Modine Manufacturing Company patents

List of Invacare Corporation patents

List of Spectra Logic patents

List of Battery Ventures portfolio companies

List of companies in Sumitomo Mitsui Trust Investment's investment portfolio

Patents where

Current Assignee

Name

is

Upsher-Smith Laboratories

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11337962 Formulations comprising triptan compounds	Patent 11337962 was granted and assigned to Upsher-Smith Laboratories on May, 2022 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	11337962	May 24, 2022
	‌ US Patent 11364224 Pharmaceutical composition for treating migraine		Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	11364224	June 21, 2022
	‌ US Patent 9456985 Sustained-released product comprising a combination of a non-opioid amine and a non-steroidal, anti-inflammatory drug	Patent 9456985 was granted and assigned to Upsher-Smith Laboratories on October, 2016 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	9456985	October 4, 2016
	‌ US Patent 9023390 Sustained-release product comprising a combination of a non-opioid amine and a non-steroidal anti-inflammatory drug	Patent 9023390 was granted and assigned to Upsher-Smith Laboratories on May, 2015 by the United States Patent and Trademark Office.		Upsher-Smith Laboratories		United States Patent and Trademark Office	9023390	May 5, 2015
	‌ US Patent 10537554 Pharmaceutical composition for treating migraine	Patent 10537554 was granted and assigned to Upsher-Smith Laboratories on January, 2020 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	10537554	January 21, 2020
	‌ US Patent 9456970 Dermatological compositions and methods	Patent 9456970 was granted and assigned to Upsher-Smith Laboratories on October, 2016 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	9456970	October 4, 2016
	‌ US Patent 8652527 Extended-release topiramate capsules	Patent 8652527 was granted and assigned to Upsher-Smith Laboratories on February, 2014 by the United States Patent and Trademark Office.		Upsher-Smith Laboratories		United States Patent and Trademark Office	8652527	February 18, 2014
	‌ US Patent 9295675 Testosterone gel compositions and related methods	Patent 9295675 was granted and assigned to Upsher-Smith Laboratories on March, 2016 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	9295675	March 29, 2016
	‌ US Patent 10172878 Extended-release topiramate capsules	Patent 10172878 was granted and assigned to Upsher-Smith Laboratories on January, 2019 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	10172878	January 8, 2019
	‌ US Patent 9662340 Testosterone gel compositions and related methods	Patent 9662340 was granted and assigned to Upsher-Smith Laboratories on May, 2017 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	9662340	May 30, 2017
	‌ US Patent 8013017 Dermatological compositions and methods	Patent 8013017 was granted and assigned to Upsher-Smith Laboratories on September, 2011 by the United States Patent and Trademark Office.		Upsher-Smith Laboratories		United States Patent and Trademark Office	8013017	September 6, 2011
	‌ US Patent 9101545 Extended-release topiramate capsules	Patent 9101545 was granted and assigned to Upsher-Smith Laboratories on August, 2015 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	9101545	August 11, 2015
	‌ US Patent 8889190 Extended-release topiramate capsules	Patent 8889190 was granted and assigned to Upsher-Smith Laboratories on November, 2014 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	8889190	November 18, 2014
	‌ US Patent 8785426 Testosterone gel compositions and related methods	Patent 8785426 was granted and assigned to Upsher-Smith Laboratories on July, 2014 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	8785426	July 22, 2014
	‌ US Patent 9555005 Extended-release topiramate capsules	Patent 9555005 was granted and assigned to Upsher-Smith Laboratories on January, 2017 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	9555005	January 31, 2017
	‌ US Patent 10603305 Formulations comprising triptan compounds	Patent 10603305 was granted and assigned to Upsher-Smith Laboratories on March, 2020 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	10603305	March 31, 2020
	‌ US Patent 10363224 Extended-release topiramate capsules	Patent 10363224 was granted and assigned to Upsher-Smith Laboratories on July, 2019 by the United States Patent and Trademark Office.	Upsher-Smith Laboratories	Upsher-Smith Laboratories		United States Patent and Trademark Office	10363224	July 30, 2019
	‌ US Patent 8362029 Opioid-containing oral pharmaceutical compositions and methods	Patent 8362029 was granted and assigned to Upsher-Smith Laboratories on January, 2013 by the United States Patent and Trademark Office.		Upsher-Smith Laboratories		United States Patent and Trademark Office	8362029	January 29, 2013
	‌ US Patent 7056534 Coated potassium chloride granules and tablets	Patent 7056534 was granted and assigned to Upsher-Smith Laboratories on June, 2006 by the United States Patent and Trademark Office.		Upsher-Smith Laboratories		United States Patent and Trademark Office	7056534	June 6, 2006

19 results

0 selected

19 results

0 selected